Debevoise & Plimpton LLP is advising CD&R in its approximately $5.8 billion acquisition of Option Care Health (NASDAQ: OPCH), a provider of home and alternate site infusion therapy services, alongside McKesson Corporation (NYSE: MCK). It is anticipated that CD&R will eventually sell its stake to McKesson through a structured arrangement. For more information, see the press release.
The Debevoise team is led by M&A partners Christopher Anthony and Kevin Rinker and includes partner Dominique Trudelle, associates Richard Hughes, Mackenzie Mendolla, Micah Rubin, Matthew Ryan and Cailley Silbert and law clerks Lok Ngai Ho and Danielle Ramsay, finance partners Andrea Michelle Hwang and Scott Selinger, counsel Jonathan Yeung and associates Missy Aja and Monica Fainshtein, executive compensation & benefits partners Jonathan Lewis and Wendy Widman and associates Simmie Jenkelowitz and Jessica Siegel, tax partner Michael Bolotin and associates Shanna Adler, Travis Long and Elliott Tuchman, capital markets partners Benjamin Pedersen and Steven Slutzky and associates Jason Auman and Helen Fan, IP and technology transactions partner Henry Lebowitz and associate Siena Stanislaus, antitrust partners Ted Hassi and Rebekah Scherr and associates Sabine Violetta Kobienia and Lillian Lara, and litigation counsel Jacob Stahl and associate Kaitlyn McGill.